Abstract
Background Social determinants of health (SDOH) may be related to CV risk in women with and without breast cancer (BC).
Methods In 153,401 women without prevalent CV disease in the Women’s Health Initiative (WHI), SDOH factors included geographic region, rurality, insurance status, and household income. Cox proportional hazard models were used to assess associations between SDOH factors and a composite CV outcome (myocardial infarction, stroke, hospitalization for heart failure, or CV death). Effect modification by BC was assessed between BC status and SDOH.
Results The final cohort included 10,954 (mean age 62±7 years) women who subsequently developed BC and 142,144 (mean age 63 ± 7) women without BC. During a median follow-up of 13 years, 18,148 women had an incident composite CV outcome. Rurality, low household income, and non-private insurance were associated with an increased risk of composite CV outcome and mortality in both women with and without BC. There was no effect modification by BC status for associations with rurality, insurance, or household income. By geographic region, there was no difference in composite CV outcome in women without BC. However, there was a significant interaction by BC status for geographic region and the composite endpoint (p=0.009). Women with BC in the South had a lower risk of the composite outcome (HR 0.68, 95% CI 0.54-0.87).
Conclusions SDOH are associated with an increased risk of CV events and mortality among women. There were no differential associations based on BC status, suggesting that women with BC face similar vulnerabilities related to SDOH.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review boards from all WHI-affiliated institutions approved this study. This analysis was approved by the WHI publications and presentations committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Declarations of interest: none
Funding: The WHI program is funded by National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts, HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Data Availability
Data are accessible through the established data sharing policies for the Women?s Health Initiative at https://www.whi.org/page/working-with-whi-data.
